UNICA IRIS Institutional Research Information System

LOREFICE, LORENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 223.075
NA - Nord America 5.407
AS - Asia 982
Continente sconosciuto - Info sul continente non disponibili 13
SA - Sud America 6
OC - Oceania 4
AF - Africa 2
Totale 229.489
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 221.584
US - Stati Uniti d'America 5.373
CN - Cina 716
UA - Ucraina 443
SE - Svezia 388
DE - Germania 176
SG - Singapore 174
GB - Regno Unito 164
FI - Finlandia 136
FR - Francia 62
CA - Canada 32
NL - Olanda 25
CZ - Repubblica Ceca 21
KR - Corea 20
VN - Vietnam 20
RU - Federazione Russa 18
IN - India 16
EU - Europa 13
BE - Belgio 12
IR - Iran 12
ES - Italia 11
RO - Romania 7
TR - Turchia 7
BR - Brasile 6
IL - Israele 5
AU - Australia 4
CH - Svizzera 4
DK - Danimarca 3
GR - Grecia 3
HU - Ungheria 3
PL - Polonia 3
HK - Hong Kong 2
HR - Croazia 2
IE - Irlanda 2
TH - Thailandia 2
UZ - Uzbekistan 2
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
JP - Giappone 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
ZA - Sudafrica 1
Totale 229.489
Salva come PNG Salva come JPEG
Città #
Cagliari 216.950
Uta 4.093
Fairfield 669
Woodbridge 509
Chandler 448
Ashburn 434
Houston 349
Wilmington 323
Ann Arbor 290
Boardman 280
Nyköping 277
Seattle 261
Cambridge 212
Jacksonville 201
Dearborn 154
Nanjing 109
New York 104
Shanghai 97
Santa Clara 96
Singapore 91
Beijing 80
Helsinki 71
Boston 69
Milan 63
Nanchang 42
Norwalk 38
Redwood City 36
Shenyang 34
Hebei 32
San Diego 29
Washington 29
Guangzhou 28
Sassari 28
Jiaxing 27
Verona 23
Rome 22
Toronto 22
Hangzhou 21
Atlanta 20
Dong Ket 20
Seoul 19
Hefei 18
Changsha 16
Jinan 16
Brno 15
London 15
Los Angeles 15
Tianjin 13
Kunming 12
Taizhou 12
Domusnovas 10
Mountain View 10
Ningbo 10
Zhengzhou 10
Wuhan 9
Amsterdam 8
Parma 8
Phoenix 8
Auburn Hills 7
Augusta 7
Redmond 7
Shenzhen 7
Baotou 6
Detroit 6
Brussels 5
Florence 5
Leawood 5
Saint Petersburg 5
Sarno 5
Sestu 5
Arezzo 4
Bacoli 4
Edinburgh 4
Indiana 4
Manchester 4
Meana Sardo 4
Pune 4
Wuxi 4
Bari 3
Borås 3
Calais 3
Chengdu 3
Chicago 3
Como 3
Hackney 3
Jinhua 3
Lanzhou 3
Liedekerke 3
Livorno 3
Monteveglio 3
New Bedfont 3
Nürnberg 3
Palermo 3
Prague 3
Putignano 3
Quartu Sant'elena 3
Raviscanina 3
Sabz 3
San Mateo 3
Stockholm 3
Totale 227.073
Salva come PNG Salva come JPEG
Nome #
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.786
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.062
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.802
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.438
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.340
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.259
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.180
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.092
Overexpression of the cytokine BAFF and autoimmunity risk 3.907
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.889
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.888
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.758
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.718
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.692
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.691
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.676
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.569
Walking improvements with nabiximols in patients with multiple sclerosis 3.557
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.529
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.485
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.481
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.430
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.412
A genetic association study of two genes linked to neurodegeneration in a Sardinian multiple sclerosis population: The TARDBP Ala382Thr mutation and C9orf72 expansion 3.381
Impact of the media on future hope in multiple sclerosis 3.298
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.282
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.275
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.184
Multiple Sclerosis and environmental factors. 3.177
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.165
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.159
Oral agents in multiple sclerosis 3.107
‘Timed up and go’ and brain atrophy: a preliminary MRI study to assess functional mobility performance in multiple sclerosis 3.065
Influence of treatments in multiple sclerosis disability: a cohort study 3.048
Top-down proteomic profiling of human saliva in multiple sclerosis patients 3.018
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 2.966
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 2.936
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 2.905
Smoothness of gait, but not spatio-temporal parameters, are altered in early stages of Multiple Sclerosis 2.902
Refining the connection between gait and cognition: training the body to improve the brain 2.860
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.854
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 2.853
Is There Any Relationship between Upper and Lower Limb Impairments in People with Multiple Sclerosis? A Kinematic Quantitative Analysis 2.798
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.754
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.718
Hourly trends of physical activity in people with Multiple Sclerosis 2.668
Perception of risk and shared decision making process in multiple sclerosis 2.552
Postural adaptation during a Nintendo Wii balance training 2.551
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.454
Are static and dynamic balance abilities correlated in people with Multiple Sclerosis? 2.432
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.345
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.226
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.224
The cohort of the multiple sclerosis center of Cagliari 2.222
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.176
Induction and escalation therapies in multiple sclerosis 2.169
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.124
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.011
Epidemiology of multiple sclerosis in south-western Sardinia 1.807
The risk of bipolar disorders in multiple sclerosis 1.782
Coenzyme Q10 in the cerebrospinal fluid of multiple sclerosis patients 1.746
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.685
Facial synkinesis as a first symptom of multiple sclerosis 1.678
The impact of deep grey matter volume on cognition in Multiple Sclerosis 1.674
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study 1.671
Evaluation of FMR1 gene premutation in Sardinians multiple sclerosis 1.638
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 1.609
Occurence of autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.590
Characterization of gait abnormalities in individuals affected by multiple sclerosis by means of the Gait Profile Score 1.544
Monoclonal antibodies: a target therapy for multiple sclerosis 1.389
Relationship between HLA DRB1-DQB1 haplotypes and oligoclonal IgG bands in Sardinians MS patients 1.344
Multiple sclerosis and bipolar disorders: the burden of comorbidity and its consequences on quality of life 1.325
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 1.310
Autoimmune diseases in Sardinian multiple sclerosis patients and in their first degree relatives 1.296
Delayed effect of age at onset on disability progression in multiple sclerosis 1.228
Q10 in the CSF of MS patients 1.064
Coenzyme Q10 in the CSF of MS patients 1.055
Gait initiation evaluation in multiple sclerosis 1.015
Postural sway analysis as tool to assess balance impairments in individuals with multiple sclerosis 990
Epidemiology of multiple sclerosis in south western Sardinia: nature versus nurture 969
Optic Neuritis: a common MS symptom or a peculiar phenotype? 941
null 864
Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study 863
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 813
1H-NMR-Based Metabolomics in Autism Spectrum Disorder and Pediatric Acute-Onset Neuropsychiatric Syndrome 795
Optic Neuritis: a common MS symptom or a specific phenotype? 790
null 756
Sex Hormones as Key Modulators of the Immune Response in Multiple Sclerosis: A Review 705
Event-related potentials and deep grey matter atrophy in multiple sclerosis: Exploring the possible associations with cognition 662
Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives 547
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperium 516
Evolution of teriflunomide use in multiple sclerosis: A real-world experience 495
The impact of the secondary infections in ICU patients affected by COVID-19 during three different phases of the SARS-CoV-2 pandemic 433
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis 314
Omics approaches to understanding the efficacy and safety of disease-modifying treatments in multiple sclerosis 253
Role of geo-chemical environmental factors in multiple sclerosis distribution in the south-western Sardinia 225
Totale 229.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 258.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 258.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202035.625 0 0 0 0 14.100 9.758 5.464 1.273 744 1.041 899 2.346
2020/202160.051 1.745 2.522 2.620 14.961 10.407 7.317 4.372 4.357 2.357 3.724 3.563 2.106
2021/202210.954 1.592 696 461 995 913 567 508 535 1.181 1.097 1.293 1.116
2022/202314.199 1.396 2.257 2.026 1.160 1.055 1.369 560 1.113 749 795 1.081 638
2023/202414.580 913 929 687 1.163 1.403 2.471 1.405 1.413 690 980 1.249 1.277
2024/202535.695 13.999 13.815 4.271 2.541 1.069 0 0 0 0 0 0 0
Totale 229.881